FOLH1 and prostate cancer: Furthermore, 24‐month toxicity data reported in the PEACE V‐STORM trial highlighted that elective nodal pelvic radiotherapy (ENRT) and MDT with 6 months of ADT for mostly PSMA‐PET detected oligorecurrent nodal prostate cancer had acceptable toxicity rates with no clinically meaningful difference in acute gastrointestinal or genitourinary toxicity or QoL subdomains compared with baseline.15